Cryptogenic Stroke Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-03-31

Study Completion Date

2011-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether the Sleuth Implantable Loop Recorder will enhance detection of latent atrial fibrillation in patients after cryptogenic stroke.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke

NCT00924638

Cryptogenic Symptomatic Transient Ischemic Attack Cryptogenic Ischemic Stroke

COMPLETED PHASE4

Left Atrial Strain and Cryptogenic Stroke

NCT07224178

Ischemic Stroke, Cryptogenic Ischemic Stroke, Embolic Hemorrhagic Stroke +2 more

RECRUITING

Yield of Implantable Cardiac Monitoring Device in Patients With Acute Ischemic Stroke.

NCT05494034

Stroke, Acute Stroke Stroke, Ischemic +1 more

RECRUITING NA

Diagnosis by Comprehensive Cardiovascular Imaging for Stroke and TIA

NCT03618069

Stroke Transient Ischaemic Attack

UNKNOWN NA

Stepwise Screening for Silent Atrial Fibrillation After Stroke

NCT03570060

Ischemic Cerebrovascular Accident

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cryptogenic Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sleuth AT Implantable ECG Monitoring System

The study device provides monitoring only. It cannot provide intervention or treatment.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Recent stroke (within 30 days) as defined by who has a sudden onset of focal neurological deficits presumed vascular etiology and lasting more than 24 hours.
* Negative brain image for hemorrhagic stroke
* In sinus rhythm at time of enrollment

Exclusion Criteria

* Know history of atrial fibrillation
* Previous implanted cardiac device (ppM or ICD)
* Serious illness making it unlikely to survive one year
* Known secondary cause of stroke

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No